JP2001031625A - Optical resolution of carboxylic acid - Google Patents

Optical resolution of carboxylic acid

Info

Publication number
JP2001031625A
JP2001031625A JP11201586A JP20158699A JP2001031625A JP 2001031625 A JP2001031625 A JP 2001031625A JP 11201586 A JP11201586 A JP 11201586A JP 20158699 A JP20158699 A JP 20158699A JP 2001031625 A JP2001031625 A JP 2001031625A
Authority
JP
Japan
Prior art keywords
carboxylic acid
methyl
optical resolution
salt
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11201586A
Other languages
Japanese (ja)
Inventor
Hiroshi Nagase
長瀬  博
Hideo Yoshihara
秀夫 吉原
Hisanobu Wakita
尚宜 脇田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP11201586A priority Critical patent/JP2001031625A/en
Publication of JP2001031625A publication Critical patent/JP2001031625A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an industrially practicable method for mass producing a raw material of an optically active substance such as a compound useful as a structural raw material for iloprost, etc., being an antithrombotic agent by subjecting a specific carboxylic acid to optical resolution using quinine, etc. SOLUTION: (A) A carboxylic acid of the formula (R1 and R2 are each a lower alkyl; n is 0-3) [preferably (±)-2-methyl-4-hexynoic acid] is subjected to optical resolution by using (B) quinine or cinchonidine to carry out the optical resolution of the objective compound. In this method, the component A is brought into contact with the component B in a solvent such as methanol, etc., to form a disastereomer salt, which is cooled and/or concentrated to precipitate a slightly soluble diastereomer salt. The diastereomer salt is separated by filtration, recrystallized and further purified. A raw material such as dimethyl 3-methyl-2-oxo-5-heptynylphosphonate, etc., is obtained by the method.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、例えば医薬品の中
で抗血栓剤として有用であるアイロプロスト、シカプロ
スト、エプタプロスト、ベラプロストのω側鎖の製造原
料として用いられるジメチル 3-メチル-2-オキソ-5-ヘ
プチニルホスホネートあるいはジメチル3-メチル-2-オ
キソ-5-オクチニルホスホネートの光学活性体の原料の
製造方法に関する。
The present invention relates to dimethyl 3-methyl-2-oxo used as a raw material for producing the ω side chain of iloprost, cicaprost, eptaprost and beraprost, which are useful as antithrombotic agents in pharmaceuticals, for example. The present invention relates to a method for producing a raw material of an optically active substance of -5-heptynylphosphonate or dimethyl 3-methyl-2-oxo-5-octynylphosphonate.

【0002】[0002]

【従来の技術】従来、ジメチル 3-メチル-2-オキソ-5-
ヘプチニルホスホネートあるいはジメチル 3-メチル-2
-オキソ-5-オクチニルホスホネートの原料である2-メチ
ル-4-ヘキシン酸あるいは2-メチル-4-ヘプチン酸の光学
活性体は、フェニルグリシノールのアミド誘導体に変換
してジアステレオマーをカラムクロマトグラフィーによ
り精製するか(Angew. Chem. Int. Ed. Engl. 1979, 1
8, 62; ibid. 1979, 18, 63) 、ノルエフェドリンから
得られるオキサゾリジノン誘導体を原料に用いて不斉ア
ルキル化を行う方法(Liebig Ann. Chem. 1989, 1081)
が知られていた。
2. Description of the Related Art Conventionally, dimethyl 3-methyl-2-oxo-5-
Heptynyl phosphonate or dimethyl 3-methyl-2
The optically active form of 2-methyl-4-hexynic acid or 2-methyl-4-heptic acid, which is the raw material of 2-oxo-5-octynylphosphonate, is converted to an amide derivative of phenylglycinol and the diastereomer is converted to a column. Purification by chromatography (Angew. Chem. Int. Ed. Engl. 1979, 1
8, 62; ibid. 1979, 18, 63) and asymmetric alkylation using an oxazolidinone derivative obtained from norephedrine as a raw material (Liebig Ann. Chem. 1989, 1081).
Was known.

【0003】[0003]

【発明が解決しようとする課題】しかし、前述の従来法
のうち、前者の方法は合成ルートが長く、カラムクロマ
トグラフィーによる精製を行うため工業的な製造方法と
はいえない。また、後者の方法も-78℃という低温で行
う必要があることと不斉収率が80%なので反応後再結
晶を繰り返さなければいけないことが問題であった。さ
らに原料のノルエフェドリンは覚醒剤の原料であるた
め、入手が非常に困難である。
However, of the above-mentioned conventional methods, the former method has a long synthesis route, and cannot be said to be an industrial production method due to purification by column chromatography. In addition, the latter method also has a problem that it must be performed at a low temperature of -78 ° C. and that the recrystallization must be repeated after the reaction because the asymmetric yield is 80%. Furthermore, since the raw material norephedrine is a raw material of a stimulant, it is very difficult to obtain it.

【0004】また、光学純度の分析法として知られてい
る高速液体クロマトグラフィー法を光学分割に適用する
ことも可能であるが、高価な担体を必要とし工業生産は
コストがかかる。
[0004] High-performance liquid chromatography, which is known as an optical purity analysis method, can also be applied to optical resolution, but requires an expensive carrier and requires industrial production at a high cost.

【0005】本発明は、前述のカルボン酸の光学活性体
を大量に得る工業的に実用化可能な製造方法を提供する
ことを目的とする。
An object of the present invention is to provide an industrially practical production method for obtaining a large amount of the above-mentioned optically active carboxylic acid.

【0006】[0006]

【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意検討し、前述のカルボン酸と特定
の光学活性なアミンとのジアステレオマー塩の再結晶を
行う光学分割法を発明するに至った。
Means for Solving the Problems The present inventors have studied diligently to solve the above-mentioned problems, and have obtained an optical resolution for recrystallization of a diastereomer salt of the above-mentioned carboxylic acid and a specific optically active amine. Invented the law.

【0007】すなわち、本発明は一般式(1)That is, the present invention provides a compound represented by the general formula (1):

【0008】[0008]

【化2】 [式中、R1、R2は低級アルキル基を表し、nは0-3の整
数を表す]で表されるカルボン酸をキニーネあるいはシ
ンコニジンを用いて光学分割する方法である。
Embedded image [Wherein, R 1 and R 2 represent a lower alkyl group, and n represents an integer of 0-3]. This is a method of optically resolving a carboxylic acid represented by the formula: quinine or cinchonidine.

【0009】[0009]

【発明の実施の形態】本発明は一般式(1)DETAILED DESCRIPTION OF THE INVENTION The present invention provides a compound represented by the general formula (1):

【0010】[0010]

【化3】 [式中、R1、R2は低級アルキル基を表し、nは0-3の整
数を表す]で表されるカルボン酸をキニーネあるいはシ
ンコニジンを用いて光学分割する方法であり、詳しく
は、キニーネと一般式(1)のカルボン酸、あるいはシ
ンコニジンと一般式(1)のカルボン酸とのジアステレ
オマー塩を形成させ、その溶解度の差を利用して光学分
割する方法に関するものである。
Embedded image [Wherein, R 1 and R 2 represent a lower alkyl group, and n represents an integer of 0-3]. This is a method of optically resolving a carboxylic acid represented by the formula: quinine or cinchonidine. And a carboxylic acid of the general formula (1), or a diastereomeric salt of cinchonidine and the carboxylic acid of the general formula (1), and a method for optical resolution using the difference in solubility.

【0011】上記一般式(1)のカルボン酸において、
R1、R2の低級アルキル基としては、炭素数1〜4のアル
キル基、具体的にはメチル基、エチル基、n-プロピル
基、イソプロピル基、シクロプロピル基、n-ブチル基等
が挙げられ、R1とR2は同じであっても異なってもよい。
nは1または2が好ましい。中でもR1とR2がともにメチ
ルであり、nが1または2であるものが好ましい。
In the carboxylic acid of the general formula (1),
Examples of the lower alkyl group for R 1 and R 2 include an alkyl group having 1 to 4 carbon atoms, specifically, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, a cyclopropyl group, and an n-butyl group. And R 1 and R 2 may be the same or different.
n is preferably 1 or 2. Among them, those in which both R 1 and R 2 are methyl and n is 1 or 2 are preferred.

【0012】本発明において、原料として用いられる一
般式(1)のカルボン酸のうち、たとえばR1とR2がいず
れもメチル基で、nが1である2-メチル-4-ヘキシン酸
はTetrahedron, 1999, 55, 2449に記載の方法により製
造できるが、もちろんこれ以外の方法で製造したもので
あっても何ら問題はない。また、原料のカルボン酸は
(+)体、(-)体を等量含むラセミ混合物だけでなく、いず
れか一方の光学異性体を等量以上含む混合物も包含す
る。
In the present invention, among the carboxylic acids of the general formula (1) used as raw materials, for example, 2-methyl-4-hexanoic acid in which both R 1 and R 2 are methyl groups and n is 1 is Tetrahedron , 1999, 55, 2449, but of course, there is no problem if it is produced by any other method. The raw material carboxylic acid is
Not only a racemic mixture containing equal amounts of the (+)-form and (-)-form, but also a mixture containing at least one of the optical isomers in an equal amount or more.

【0013】本発明の実施態様としては、まず溶媒中で
一般式(1)のカルボン酸とキニーネあるいはシンコニ
ジンを接触させて、ジアステレオマー塩をつくる。ここ
で使用する溶媒としては、水、メタノール、エタノー
ル、n-プロパノール、イソプロパノールなどのプロトン
性溶媒、アセトン、アセトニトリル、酢酸エチル、クロ
ロホルム、トルエンなどの有機溶媒またはこれらの混合
溶媒を用いることができる。なかでも、メタノール、水
またはこれらの混合溶媒が好ましい。
In an embodiment of the present invention, first, a carboxylic acid of the general formula (1) is brought into contact with quinine or cinchonidine in a solvent to form a diastereomer salt. Examples of the solvent used here include water, protic solvents such as methanol, ethanol, n-propanol, and isopropanol; organic solvents such as acetone, acetonitrile, ethyl acetate, chloroform, and toluene; and mixed solvents thereof. Among them, methanol, water or a mixed solvent thereof is preferable.

【0014】分割剤のキニーネ、シンコニジンはともに
キナ皮からの抽出物から得られるキナアルカロイドの1
つであり、市販されているため入手容易な化合物であ
る。分割剤としてキニーネを用いた場合には(-)体の、
シンコニジンを用いた場合には(+)体のカルボン酸が得
られる。キニーネあるいはシンコニジンの使用量に特に
限定はないが、カルボン酸1モルに対して通常0.3-1.5
モル、好ましくは0.5-1.2モルの分割剤を接触させてジ
アステレオマー塩をつくる。この時、アンモニア、ジメ
チルアミン、ジエチルアミン、ジイソプロピルアミンな
どのアミンを共存させてもよい。
The resolving agents quinine and cinchonidine are both quinacalkaloids obtained from extracts from quinna rind.
And a commercially available compound that is easily available. When quinine is used as a resolving agent,
When cinchonidine is used, a (+)-form carboxylic acid is obtained. Although the amount of quinine or cinchonidine is not particularly limited, it is usually 0.3-1.5 per mole of carboxylic acid.
A mole, preferably 0.5-1.2 mole, of the resolving agent is contacted to form a diastereomer salt. At this time, an amine such as ammonia, dimethylamine, diethylamine or diisopropylamine may coexist.

【0015】カルボン酸(1)に分割剤を接触させる方
法としては、前記溶媒中にラセミ体のカルボン酸および
分割剤を一挙に加えてもよいし、それらを順次加えても
よい。さらにあらかじめラセミ体のカルボン酸と分割剤
からつくった塩を前記溶媒中に溶解させてもよい。
As a method of bringing the resolving agent into contact with the carboxylic acid (1), the racemic carboxylic acid and the resolving agent may be added to the solvent at once, or they may be added sequentially. Further, a salt prepared from a racemic carboxylic acid and a resolving agent in advance may be dissolved in the solvent.

【0016】次にこうして得られたジアステレオマー塩
を含む溶液を冷却および/あるいは濃縮すると、難溶性
のジアステレオマー塩が溶液から晶出してくる。難溶性
のジアステレオマー塩を溶液から析出させる際の温度は
使用する溶媒の凝固点から沸点の範囲であればよく、目
的に応じて適宜決められるが、通常は0℃から100℃
の範囲で十分である。難溶性のジアステレオマー塩の結
晶は、ろ過、遠心分離などの通常の固液分離法によって
容易に分離することができる。
Next, when the solution containing the diastereomer salt thus obtained is cooled and / or concentrated, a sparingly soluble diastereomer salt crystallizes out of the solution. The temperature at which the sparingly soluble diastereomer salt is precipitated from the solution may be within the range of the freezing point to the boiling point of the solvent used, and is appropriately determined depending on the purpose.
Is sufficient. Crystals of the sparingly soluble diastereomer salt can be easily separated by ordinary solid-liquid separation methods such as filtration and centrifugation.

【0017】再結晶で得られたジアステレオマー塩を硫
酸や塩酸などの鉱酸で処理した後、有機溶媒で抽出、濃
縮し、必要に応じて蒸留、再結晶、カラムクロマトグラ
フィー等の精製操作を行うことにより、高純度の光学純
度を持つ一般式(1)のカルボン酸が得られる。
The diastereomer salt obtained by recrystallization is treated with a mineral acid such as sulfuric acid or hydrochloric acid, and then extracted and concentrated with an organic solvent. If necessary, purification operations such as distillation, recrystallization, and column chromatography are performed. Is carried out to obtain a carboxylic acid of the general formula (1) having high optical purity.

【0018】本発明で用いる分割剤はいずれも水に難溶
性であり、ジアステレオマー塩から高収率で回収するこ
とができ、しかも回収過程で分解、ラセミ化することは
ほとんどない。したがって、分割剤は光学純度が保持さ
れているので再使用して光学分割を行うことができる。
All of the resolving agents used in the present invention are hardly soluble in water, can be recovered from diastereomeric salts in high yield, and hardly decompose or racemize during the recovery process. Therefore, since the resolving agent maintains the optical purity, it can be reused to perform optical resolution.

【0019】本発明により、一般式(1)で表されるカ
ルボン酸の光学活性体を、入手容易な光学活性なアミン
を用いることによって製造することが可能となった。本
製造法は、実験的製法、工業的製法いずれにおいても適
応できるので非常に有用である。
According to the present invention, it has become possible to produce an optically active carboxylic acid represented by the general formula (1) by using a readily available optically active amine. This production method is very useful because it can be applied to both experimental production methods and industrial production methods.

【0020】以下、実施例を挙げて本発明をさらに詳細
に説明する。
Hereinafter, the present invention will be described in more detail with reference to examples.

【0021】[0021]

【実施例】実施例1 (-)-2-メチル-4-ヘキシン酸の光学分割 (±)-2-メチル-4-ヘキシン酸155.6gをキニーネ400g、メ
タノール500gを採取し、メタノール還流下に溶解した。
溶解後、攪拌しながら水500gを加えて室温まで冷却し
た。その後、-10〜+5℃に冷却放置した。析出したジア
ステレオマー塩はろ過、減圧乾燥すると226.0g(晶析率
40.7%、(-)体67.6%e.e.)であった。母液は(+)体49.0%
e.e.であった。
EXAMPLES Example 1 Optical Resolution of (-)-2-Methyl-4-hexynic acid 155.6 g of (±) -2-methyl-4-hexynic acid was collected from 400 g of quinine and 500 g of methanol, and refluxed with methanol. Dissolved.
After dissolution, 500 g of water was added with stirring, and the mixture was cooled to room temperature. Then, it was left to cool to -10 to + 5 ° C. The precipitated diastereomer salt was filtered and dried under reduced pressure to obtain 226.0 g (crystallization rate).
40.7% and (-) form 67.6% ee). Mother liquor is (+) body 49.0%
was ee.

【0022】第1晶の塩225gをメタノール225gに加熱溶
解した。溶解後、攪拌しながら水225gを加え、0℃に冷
却静置した。析出したジアステレオマー塩はろ過、減圧
乾燥すると192g(晶析率86.9%、(-)体88.1%e.e.)であ
った。母液は(+)体47.2%e.e.であった。
225 g of the first crystal salt was dissolved by heating in 225 g of methanol. After dissolution, 225 g of water was added with stirring, and the mixture was cooled to 0 ° C. and allowed to stand. The precipitated diastereomer salt was filtered and dried under reduced pressure to give 192 g (crystallization rate: 86.9%, (-) form: 88.1% ee). The mother liquor was (+) form 47.2% ee.

【0023】第2晶の塩を更にメタノール-水混合溶媒
を用いて8回再結晶精製し、ジアステレオマー塩35.0g
(全収率6.3%、(-)体99.9%e.e.。[α]D=-143.3°(c 1.
95, EtOH)が得られた。10晶の母液は(-)体99.6%e.e.で
あった。
The second crystal salt was further recrystallized and purified eight times using a methanol-water mixed solvent to obtain 35.0 g of a diastereomer salt.
(Total yield 6.3%, (-) form 99.9% ee. [Α] D = -143.3 ° (c 1.
95, EtOH). The mother liquor of 10 crystals was (-) form 99.6% ee.

【0024】第10晶の塩34gに2N H2SO4200ml、酢酸エチ
ル500ml、10%食塩水500mlを用いて抽出、洗浄したあ
と、有機相をMgSO4で乾燥した。混合液をろ過し、ろ液
を濃縮、減圧蒸留して(-)-2-メチル-4-ヘキシン酸9.1g
(bp 82.5-84.0℃/1.5-2.0mmHg、[α]D=-0.72°(c 1
0.0, EtOH)、(-)体99.9%e.e.)が得られた。
After extracting and washing 200 g of 2N H 2 SO 4 , 500 ml of ethyl acetate, and 500 ml of 10% saline, 34 g of the salt of the 10th crystal was washed, and the organic phase was dried over MgSO 4. The mixture was filtered, and the filtrate was concentrated and distilled under reduced pressure to give (-)-2-methyl-4-hexamic acid 9.1 g.
(Bp 82.5-84.0 ° C / 1.5-2.0 mmHg, [α] D = -0.72 ° (c 1
0.0, EtOH) and (-)-form 99.9% ee) were obtained.

【0025】光学純度分析法 窒素気流下に、(-)-2-メチル-4-ヘキシン酸126.2mg、ト
ルエン2mlと塩化チオニル109μLを採取し、加熱して酸
クロリドに誘導した。別に窒素気流下にL-(-)-α-フェ
ネチルアミン243mg、THF2.5mL、トリエチルアミン278μ
Lを採取し、氷冷下に酸クロリド混合溶液を加えてアミ
ド化した(反応はTLC分析により確認した。酢酸エチル
/シクロヘキサン=1/2、Rf値:カルボン酸 0.57、アミ
ド 0.26)。反応混合物に水、酢酸エチルを加えて攪
拌、分液し、有機相を1mol/L塩酸、10%食塩水で洗浄
し、MgSO4で乾燥した後、ろ過した。ろ液を濃縮乾固
し、20mgを1mLのエタノールに溶解し、HPLC分析した。
Optical Purity Analysis Method Under a nitrogen stream, (-)-2-methyl-4-hexynic acid (126.2 mg), toluene (2 ml) and thionyl chloride (109 μL) were collected and heated to induce acid chloride. Separately under a nitrogen stream L-(-)-α-phenethylamine 243 mg, THF 2.5 mL, triethylamine 278 μ
L was collected and amidated by adding an acid chloride mixed solution under ice cooling (reaction was confirmed by TLC analysis. Ethyl acetate / cyclohexane = 1/2, Rf value: carboxylic acid 0.57, amide 0.26). Water and ethyl acetate were added to the reaction mixture, and the mixture was stirred and separated. The organic phase was washed with 1 mol / L hydrochloric acid and 10% brine, dried over MgSO4, and filtered. The filtrate was concentrated to dryness, 20 mg was dissolved in 1 mL of ethanol and analyzed by HPLC.

【0026】使用カラム:YMC-A-014(SIL) カラム温度:40℃ 検出波長:UV254nm 展開液:n-ヘキサン/ジクロロメタン/エタノール=88/
10/2(v/v/v) 流速:0.8mL/min 保持時間:(-)-2-メチル-4-ヘキシン酸のアミド 40分 (+)-2-メチル-4-ヘキシン酸のアミド 32分 実施例2 (+)-2-メチル-4-ヘキシン酸の光学分割 キニーネで分割した実施例1の第1,2晶の母液を後処
理、蒸留して得られた(+)体を多く含む2-メチル-4-ヘキ
シン酸351.5g(bp:115-118℃/9-10mmHg、(+)体49.0%e.
e.)、シンコニジン820gとメタノール1kgを5Lのフラス
コに採取し、加熱溶解した。溶解後、水1.1kgを加えて0
-5℃で5日間静置した。析出したジアステレオマーの塩
はろ過、減圧乾燥すると、532g(晶析率 45.4%、(+)体
76.1%e.e.)であった。母液は(+)体29.2%e.e.であっ
た。
Column used: YMC-A-014 (SIL) Column temperature: 40 ° C. Detection wavelength: UV 254 nm Developing solution: n-hexane / dichloromethane / ethanol = 88 /
10/2 (v / v / v) Flow rate: 0.8 mL / min Retention time: (-)-2-methyl-4-hexanoic acid amide 40 minutes (+)-2-methyl-4-hexanoic acid amide 32 Example 2 Optical Resolution of (+)-2-Methyl-4-hexynoic Acid The post-treatment and distillation of the mother liquor of the first and second crystals of Example 1 separated by quinine resulted in many (+)-forms. 351.5 g of 2-methyl-4-hexanoic acid containing (bp: 115-118 ° C / 9-10 mmHg, (+) form 49.0% e.
e.), 820 g of cinchonidine and 1 kg of methanol were collected in a 5 L flask and dissolved by heating. After dissolution, add 1.1 kg of water to 0
It was left at -5 ° C for 5 days. The precipitated diastereomer salt was filtered and dried under reduced pressure to give 532 g (crystallization rate 45.4%, (+) form
76.1% ee). The mother liquor was (+) 29.2% ee.

【0027】第1晶の塩531gをメタノール800gに加熱溶
解した。溶解後、攪拌しながら、水800gを加え、0-5℃
に7日間冷却静置した。析出したジアステレオマー塩は
ろ過、減圧乾燥すると361g(晶析率:67.9%、(+)体89.3
%e.e.)であった。母液は(+)体48.1%e.e.であった。
531 g of the first crystal salt was dissolved by heating in 800 g of methanol. After dissolution, with stirring, add 800 g of water, 0-5 ° C
For 7 days. The precipitated diastereomer salt was filtered and dried under reduced pressure to give 361 g (crystallinity: 67.9%, (+) form 89.3%).
% ee). The mother liquor was (+) form 48.1% ee.

【0028】第2晶の塩をさらにメタノール−水混合溶
媒を用いて7回再結晶し、ジアステレオマー塩 80.0g
(全収率 6.8%、(+)体99.6%e.e.、[α]D=-98.1°(c 2.
15, EtOH)が得られた。10晶の母液は(+)体98.8%e.e.で
あった。
The second crystal salt was further recrystallized seven times using a mixed solvent of methanol and water to obtain 80.0 g of a diastereomer salt.
(Total yield 6.8%, (+) form 99.6% ee, [α] D = -98.1 ° (c 2.
15, EtOH). The mother liquor of 10 crystals was (+)-form 98.8% ee.

【0029】第9晶の塩 79gに2mol/L硫酸375mL、酢酸
エチル 500mL、10%食塩水500mLを用いて後処理、抽
出、洗浄した後、有機相をMgSO4で乾燥した。これをろ
過し、ろ液を濃縮、減圧蒸留して(+)-2-メチル-4-ヘキ
シン酸21.9g(bp 79.0-81.0/1.5mmHg、[α]D=+0.97°
(c 10.1, EtOH)、(+)体99.6%e.e.)が得られた。光学
純度分析法は実施例1に同じ。
After working up, extracting and washing 79 g of the salt of the ninth crystal with 375 mL of 2 mol / L sulfuric acid, 500 mL of ethyl acetate and 500 mL of 10% saline, the organic phase was dried over MgSO 4. This was filtered, and the filtrate was concentrated and distilled under reduced pressure to give (+)-2-methyl-4-hexic acid 21.9 g (bp 79.0-81.0 / 1.5 mmHg, [α] D = + 0.97 °
(c 10.1, EtOH), (+) form 99.6% ee) were obtained. The optical purity analysis was the same as in Example 1.

【0030】[0030]

【発明の効果】本発明により、(±)ー2ーメチルー4
ーヘキシン酸を代表とするα-アルキル-アセチレンカル
ボン酸の光学活性体を、入手容易な光学活性なアミンを
用いることによって製造することが可能となった。本製
造法は、実験的製法、工業的製法いずれにおいても適応
できるので非常に有用である。
According to the present invention, (±) -2-methyl-4
It has become possible to produce an optically active α-alkyl-acetylene carboxylic acid represented by -hexyne acid by using a readily available optically active amine. This production method is very useful because it can be applied to both experimental production methods and industrial production methods.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】一般式(1) 【化1】 [式中、R1、R2は低級アルキル基を表し、nは0-3の整
数を表す]で表されるカルボン酸をキニーネまたはシン
コニジンを用いて光学分割する方法。
1. A compound of the general formula (1) Wherein R 1 and R 2 each represent a lower alkyl group, and n represents an integer of 0 to 3; and a carboxylic acid represented by the formula: quinine or cinchonidine.
【請求項2】一般式(1)で表されるカルボン酸が、
R1、R2がともにメチル基、nが1である(±)ー2ーメ
チルー4ーヘキシン酸である請求項1記載の方法。
2. A carboxylic acid represented by the general formula (1):
The method according to claim 1, wherein both R 1 and R 2 are a methyl group and n is 1 (±) -2-methyl-4-hexanoic acid.
JP11201586A 1999-07-15 1999-07-15 Optical resolution of carboxylic acid Pending JP2001031625A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11201586A JP2001031625A (en) 1999-07-15 1999-07-15 Optical resolution of carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11201586A JP2001031625A (en) 1999-07-15 1999-07-15 Optical resolution of carboxylic acid

Publications (1)

Publication Number Publication Date
JP2001031625A true JP2001031625A (en) 2001-02-06

Family

ID=16443521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11201586A Pending JP2001031625A (en) 1999-07-15 1999-07-15 Optical resolution of carboxylic acid

Country Status (1)

Country Link
JP (1) JP2001031625A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017162667A1 (en) 2016-03-22 2017-09-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Process for the preparation of triple-bond-containing optically active carboxylic acids, carboxylate salts and carboxylic acid derivatives
CN110467580A (en) * 2018-05-10 2019-11-19 华润赛科药业有限责任公司 The method for splitting of the western Nader's axial chirality enantiomer of thunder

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017162667A1 (en) 2016-03-22 2017-09-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Process for the preparation of triple-bond-containing optically active carboxylic acids, carboxylate salts and carboxylic acid derivatives
CN109196111A (en) * 2016-03-22 2019-01-11 奇诺因药物和化学工厂私人有限公司 The method for being used to prepare the optically active carboxylic acid, carboxylate and carboxylic acid derivates that contain three keys
JP2019509052A (en) * 2016-03-22 2019-04-04 キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・ゼー・エル・テー A method for producing an optically active carboxylic acid, carboxylate salt and carboxylic acid derivative containing a triple bond.
US11008594B2 (en) 2016-03-22 2021-05-18 Chinoin Pharmaceutical And Chemical Works Private Company Ltd. Process for the preparation of triple-bond-containing optically active carboxylic acids, carboxylate salts and carboxylic acid derivatives
TWI745362B (en) * 2016-03-22 2021-11-11 匈牙利商齊諾應醫藥及化學品私人有限公司 Process for the preparation of triple-bond-containing optically active carboxylic acids, carboxylate salts and carboxylic acid derivatives
CN109196111B (en) * 2016-03-22 2022-03-11 奇诺因药物和化学工厂私人有限公司 Process for producing optically active carboxylic acids, carboxylic acid salts and carboxylic acid derivatives containing triple bonds
JP7037497B2 (en) 2016-03-22 2022-03-16 キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・ゼー・エル・テー A method for producing an optically active carboxylic acid, a carboxylate salt and a carboxylic acid derivative containing a triple bond.
CN110467580A (en) * 2018-05-10 2019-11-19 华润赛科药业有限责任公司 The method for splitting of the western Nader's axial chirality enantiomer of thunder

Similar Documents

Publication Publication Date Title
JPS581105B2 (en) Optically active amino acid-mandelic acid complex and method for producing the same
KR100838922B1 (en) PROCESS FOR THE PRODUCTION OF R+¥á-LIPOIC ACID
JP2001031625A (en) Optical resolution of carboxylic acid
JP4138928B2 (en) Method for producing D-alloisoleucine and intermediate for production
JP3209041B2 (en) Optical resolving agent and process for producing optically active tetrahydrofurancarboxylic acids using the same
EP0623108A1 (en) Preparation of optically active aliphatic carboxylic acids.
JP2555244B2 (en) Novel optically active tert-leucine.1- (4-methylphenyl) ethanesulfonate and its production method
US5578734A (en) Method for the preparation of S-(+)-ethodolic acid and saline derivatives
EP0174358A1 (en) Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof
JP2830364B2 (en) Method for producing optically active 1-benzyl-3-hydroxypyrrolidine
JP4768145B2 (en) Optical purification method of optically active 2-phenoxypropionic acid
US20040049074A1 (en) Process for producing 3-amino-2-hydroxypropionic acid derivatives
JPH05279325A (en) Production of optically active 3-hydroxypyrolidine
JP2551216B2 (en) Process for producing optically active 1- (p-chlorophenyl) -1- (2-pyridyl) -3-dimethylaminopropane
JP3959798B2 (en) Method for optical resolution of 1- (3-methoxyphenyl) ethylamine
JP4109446B2 (en) Process for producing pure trans-2-[(α-methylbenzyl) amino] cyclopentanol as a diastereoisomer
JP2002080405A (en) Method for producing optically active carboxylic acid
US7345202B2 (en) Use of sulfamic acids as resolving agent
JPH10101629A (en) Production of optically active butyric acid derivative
US5367091A (en) Optical resolution of DL-3-acetylthio-2-methylpropionic acid using L-(+)-2-aminobutanol as resolving agent
JPH09241227A (en) New optical resolution agent
JPH035382B2 (en)
JP2576598B2 (en) Process for producing optically active 1-methyl-3-phenylpropylamine
BR112021012221A2 (en) METHOD FOR PRODUCING (5S)-4-[5-(3,5-DICHLOROPHENYL)-5-(TRIFLUOROMETHYL)-4H-ISOXAZOLE-3-YLA]-2-METHYL-BENZOIC ACID
JP2001064275A (en) Optical resolution of isocoumarin derivative